Bionano Genomics, Inc. Ratios

Ratios Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 36.55%27.41%33.18%32.61%21.54%21.38%26.49%1.23%
EBT Margin -245.63%-154.00%-294.13%-483.09%-434.64%-470.15%-643.57%-363.87%
EBIT Margin -244.28%-170.12%-255.44%-453.38%-428.79%-473.70%-595.98%-337.87%
EBITDA Margin -244.28%-170.12%-255.44%-453.38%-428.79%-473.70%-595.98%-337.87%
Operating Margin -244.28%-170.12%-255.44%-453.38%-428.79%-473.70%-595.98%-337.87%
Net Margin -245.82%-154.13%-294.34%-483.43%-402.84%-476.93%-643.74%-363.98%
FCF Margin -229.73%-168.95%-292.12%-450.59%-403.56%-457.61%-351.29%-224.28%
Efficiency
Inventory Average 1.38M2.26M3.38M7.85M21.07M26.33M17.01M
Assets Average 17.47M27.51M45.33M218.78M342.30M260.95M145.54M
Equity Average -20.04M6.88M19.35M186.10M293.26M172.78M65.77M
Invested Capital -43.50M19.17M23.70M51.41M341.06M253.30M100.01M39.17M
Asset Utilization Ratio 0.690.370.190.080.080.140.21
Leverage & Solvency
Interest Coverage Ratio -39.29-14.78-11.32-15.30-83.17-441.94-42.05
Debt to Equity -0.130.895.560.470.04
Debt Ratio 0.660.360.660.270.03
Equity Ratio -4.950.410.120.580.890.810.450.46
Times Interest Earned -39.29-14.78-11.32-15.30-83.17-441.94-42.05
Valuation
Enterprise Value -1.02M36.05M15.54M433.36M614.05M320.32M6.64M9.24M
Market Capitalization 52.57M32.85M471.81M864.66M433.51M73.41M29.41M
Return Ratios
Return on Sales -2.46%-1.54%-2.94%-4.83%-4.03%-4.77%-6.44%-3.64%
Return on Capital Employed -1.58%-22.73%-1.06%-0.39%-0.43%-1.34%-0.96%
Return on Invested Capital -0.36%
Return on Assets -1.06%-1.08%-0.91%-0.33%-0.39%-0.89%-0.77%
Return on Equity 0.92%-4.34%-2.12%-0.39%-0.45%-1.35%-1.70%